Abstract:Background: Sweet's syndrome is characterized by fever, leukocytosis, and tender erythematous papules or nodules. It is a rare condition, particularly in the pediatric population, and has recently been proposed to be an autoinflammatory disease that occurs due to innate immune system dysfunction, involving several cytokines, which causes abnormally increased inflammation. To the best of our knowledge, no report has documented the cytokine profile in a pediatric patient with Sweet's syndrome. Case presentation: A previously healthy 34-month-old Japanese girl was hospitalized because of remittent fever and pain in her right lower extremity with erythematous nodules. A skin biopsy of the eruption revealed dermal perivascular neutrophilic infiltration with no evidence of vasculitis, which led to the diagnosis of Sweet's syndrome. She was prescribed with orally administered prednisolone and a prompt response was observed; then, the prednisolone dose was tapered. During treatment she developed upper and lower urinary tract infections, after which her cutaneous symptoms failed to improve despite increasing the prednisolone dosage. To avoid long-term use of systemic corticosteroids, orally administered potassium iodide was initiated, but it was unsuccessful. However, orally administered colchicine along with prednisolone effectively ameliorated her symptoms, and prednisolone dosage was reduced again. We analyzed the circulating levels of interleukin-1β, interleukin-6, interleukin-18, neopterin, and soluble tumor necrosis factor receptors I and II, in order to clarify the pathogenesis of Sweet's syndrome. Of these cytokines, only interleukin-6 levels were elevated prior to orally administered prednisolone therapy. Following therapy, the elevated interleukin-6 levels gradually diminished to almost normal levels; interleukin-1β and interleukin-18 stayed within normal ranges throughout the treatment. Neopterin became marginally elevated after the start of treatment. Both soluble tumor necrosis factor receptor I and soluble tumor necrosis factor receptor II levels increased shortly after the onset of urinary tract infections. Conclusions: This is the first case report of pediatric Sweet's syndrome in which serum cytokine levels were investigated. Future studies should gather more evidence to elucidate the pathophysiology of Sweet's syndrome.

Azathioprine hypersensitivity: A Sweet-like syndrome

Clinical characteristics, diagnosis and management of Sweet syndrome induced by azathioprine

Concurrence of Sweet's Syndrome, Pathergy Phenomenon and Erythema Nodosum-Like Lesions.

Sweet Syndrome Associated With Mycobacterium Tuberculosis

Insights into the Characteristics of Sweet Syndrome in Patients with and Without Hematologic Malignancy

Drug-induced Erythroderma in Patients with Acquired Immunodeficiency Syndrome.

Subcutaneous Sweet Syndrome With Vasculitis Features: Case Report and Review

Sweet Syndrome as a Herpetiform Mimic: A Diagnostic Challenge

Celecoxib-induced Sweet's syndrome

Drug-induced Sweet's syndrome: A case/non-case study in the French pharmacovigilance database

Atypical Sweet syndrome: skin sinus tracts in an acutely febrile patient after lymphoma treatment: a case report

Systemic Sclerosis-Rheumatoid Arthritis Overlap Syndrome Complicated with Sweet’s Syndrome

Sweet syndrome in pregnancy: A narrative review

A Mysterious Rash Following Cardiothoracic Surgery: A Not So Sweet Ending

A case report of subcutaneous Sweet's syndrome

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario

Sweet's Syndrome Representing a Flare of Behçet's Disease.

Erythema nodosum as azathioprine hypersensitivity reaction in a patient with bullous pemphigoid

Splenic Irradiation-Induced Sweet’s Syndrome Associated with Preceding Myelofibrosis

Clinic analysis of 6 cases of the Sweet syndrome

Serum cytokine profile in pediatric Sweet's syndrome: a case report